Clinical Trials Logo

Clinical Trial Summary

This prospective single-center cohort study aims to identify the incidence of cognitive dysfunction after unruptured aneurysm operation and explore the influencing factors. The primary end point is the cognitive dysfunction at 6 months after operation.The features of cognitive function, mental status, neurological function recovery, and quality of life of patients with unruptured intracranial aneurysms at different time points would be analyzed.


Clinical Trial Description

This main topics is to identify and screen the patients with unruptured aneurysm who likely to suffer from cognitive dysfunction. All examinations were administered by a trained neuropsychologist.The assessment of cognitive function and mental state would be performed before operation and 6 months after operation, with the use of Montreal Cognitive Assessment Scale (MoCA) for the cognitive function, the Hamilton Anxiety Scale (HAMA) and the Hamilton Depression Scale (HDMA) tests for the mental state. The Cognitive dysfunction at 6 months after operation would be the primary end point, and the underlying factors responsible for the declined cognitive function would be analyze. The assessment of neurological function and quality of life would be performed before operation,3 months after operation and 6 months after operation, with the use of the Modified Rankin Scale(mRS) and the Functional Activities Questionnaire(FAQ) for the neurological function, the Richards—Campbell Sleep Questionnaire(RCSQ) and the 36-item short from health survey(SF-36) tests for the quality of life. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03494608
Study type Observational
Source Xuanwu Hospital, Beijing
Contact Jun Wang, Master
Phone (86)010-83198899
Email wangj229@126.com
Status Not yet recruiting
Phase
Start date May 2018
Completion date May 2020

See also
  Status Clinical Trial Phase
Not yet recruiting NCT02998229 - Aneurysm Treatment Using Intrasaccular Flow Diversion With the ARTISSE™ Device N/A
Active, not recruiting NCT02783339 - Neuroform Atlas Stent for Intracranial Aneurysm Treatment N/A
Active, not recruiting NCT01194388 - Axium Coil in Completing Endovascular Aneurysm Surgery Study N/A
Completed NCT00071565 - Familial Intracranial Aneurysm Study II N/A
Recruiting NCT03680742 - Contour Neurovascular System - European Pre-Market Unruptured Aneurysm N/A
Not yet recruiting NCT03663257 - Study to Evaluate Cerebral AneurysmFlow Results in Occlusion
Recruiting NCT02532517 - Study to Evaluate the Safety and Effectiveness of the CODMAN ENTERPRISE® Vascular Reconstruction Device N/A
Not yet recruiting NCT03661463 - Unruptured Intracranial Aneurysm Aspirin Trial (UIAAT). Phase 2
Not yet recruiting NCT03642821 - Intracranial Aneurysms Treatment With the OPTIMA Coil System
Active, not recruiting NCT02292017 - Prospective Packing Density With Target Coils I N/A
Active, not recruiting NCT01872741 - Minipterional Versus Pterional Craniotomy N/A
Completed NCT00993057 - Efficiency of Two Glucose Sampling Protocols for Maintenance of Euglycemia Early Phase 1
Completed NCT00777907 - Complete Occlusion of Coilable Aneurysms Phase 3
Completed NCT00777088 - Pipeline for Uncoilable or Failed Aneurysms N/A
Active, not recruiting NCT02881957 - Hypovitaminosis D in Neurocritical Patients Phase 2/Phase 3
Recruiting NCT03423290 - Safety and Efficacy Analysis of FRED™/FRED™Jr Embolic Device in Aneurysm Treatment
Active, not recruiting NCT02982200 - Medina Embolization Device In Neurovascular Aneurysm Study
Active, not recruiting NCT02609867 - A Feasibility Study to Evaluate the Safety and Effectiveness of Implantation of Flowise Cerebral Flow Diverter (Flowise) N/A
Active, not recruiting NCT01942512 - Risk Factors for Intracranial Aneurysm Recanalization After Endovascular Treatment. N/A
Recruiting NCT01811134 - Flow Diverter Stent for Endovascular Treatment of Unruptured Saccular Wide-necked Intracranial Aneurysms N/A